CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Adverum Biotechnologies, Inc.  (ADVM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Adverum Biotechnologies's Quick Ratio

ADVM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth



Select the Comparisons : Select the Ratio:                        

ADVM Quick Ratio (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
Y / Y Current Liabilities Change -60.91 % - - - -
Y / Y Cash & cash equivalent Change -18.19 % - - - -
Quick Ratio MRQ 63.95 39.26 22.45 21.72 30.56
Overall Ranking # 53 # 69 # 71 # 0 # 0
Seq. Current Liabilities Change -42.15 % -46.08 % -7.07 % 34.85 % -
Seq. Cash & cash equivalent Change -5.77 % -5.7 % -3.94 % -4.16 % -



Quick Ratio second quarter 2017 Comment
Current Liabilities decreased faster than Adverum Biotechnologies's Cash & cash equivalent, this led to improvement in Adverum Biotechnologies's Quick Ratio to 63.95, Quick Ratio remained below Adverum Biotechnologies, Inc. average.

Within Biotechnology & Drugs industry 2 other companies have achieved higher Quick Ratio than Adverum Biotechnologies in second quarter 2017. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are ADVM Segments?
See Quick Ratio ADVM on the trailing twelve month basis
Quick Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 3
Healthcare Sector # 4
Overall Market # 53


Quick Ratio Statistics
High Average Low
63.95 35.59 21.72
(Jun 30 2017)   (Sep 30 2016)


You need to upgrade your Flash Player


Financial Statements
Adverum Biotechnologies's Current Liabilities $ 3 Millions Visit ADVM's Balance sheet
Adverum Biotechnologies's Cash & cash equivalent $ 197 Millions Visit ADVM's Balance sheet
Source of ADVM's Sales Visit ADVM's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2017, within Biotechnology & Drugs Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Neuralstem, Inc.  168.29 $ 11.442  Millions$ 0.068  Millions
Adverum Biotechnologies, Inc.  63.95 $ 197.418  Millions$ 3.087  Millions
Protokinetix, Inc.  44.13 $ 0.238  Millions$ 0.005  Millions
Regenxbio Inc.  41.05 $ 162.083  Millions$ 3.948  Millions
Enzon Pharmaceuticals, Inc.  23.01 $ 11.206  Millions$ 0.487  Millions
Aerie Pharmaceuticals Inc  22.30 $ 307.919  Millions$ 13.810  Millions
Neurocrine Biosciences Inc  18.94 $ 525.020  Millions$ 27.721  Millions
Atara Biotherapeutics, Inc.  18.91 $ 217.090  Millions$ 11.481  Millions
Gtx Inc  18.83 $ 11.356  Millions$ 0.603  Millions
Fennec Pharmaceuticals Inc.  17.64 $ 10.232  Millions$ 0.580  Millions
Anavex Life Sciences Corp.  17.27 $ 24.793  Millions$ 1.436  Millions
Crispr Therapeutics Ag  17.22 $ 272.264  Millions$ 15.814  Millions
La Jolla Pharmaceutical Co  17.09 $ 141.317  Millions$ 8.271  Millions
Microbot Medical Inc.  17.03 $ 13.078  Millions$ 0.768  Millions
Organovo Holdings, Inc.  14.91 $ 54.974  Millions$ 3.688  Millions
Bluebird Bio, Inc.  14.07 $ 1,095.434  Millions$ 77.838  Millions
Obalon Therapeutics Inc  13.13 $ 60.725  Millions$ 4.625  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BERY's Profile

Stock Price

BERY's Financials

BERY's Expectations

Business Description

Fundamentals

Charts & Quotes

BERY's News

Suppliers

BERY's Competitors

Customers & Markets

Economic Indicators

BERY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com